Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001393905-22-000447
Filing Date
2022-11-10
Accepted
2022-11-10 15:52:32
Documents
65
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 RAPID THERAPEUTIC SCIENCE LABORATORIES, INC. - FORM 10-Q SEC FILING rtsl-20220930.htm   iXBRL 10-Q 646533
7 CERTIFICATION rtsl_ex311.htm EX-31.1 6688
8 CERTIFICATION rtsl_ex312.htm EX-31.2 6699
9 CERTIFICATION rtsl_ex321.htm EX-32.1 3548
10 CERTIFICATION rtsl_ex322.htm EX-32.2 3657
11 IMAGE rtsl10q_1.jpg GRAPHIC 5735
  Complete submission text file 0001393905-22-000447.txt   3070620

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rtsl-20220930_cal.xml EX-101.CAL 22608
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rtsl-20220930_def.xml EX-101.DEF 90143
4 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT rtsl-20220930_lab.xml EX-101.LAB 173040
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rtsl-20220930_pre.xml EX-101.PRE 164835
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rtsl-20220930.xsd EX-101.SCH 34277
59 EXTRACTED XBRL INSTANCE DOCUMENT rtsl-20220930_htm.xml XML 319246
Mailing Address 15800 DOOLEY RD. SUITE 200 ADDISON TX 75001
Business Address 15800 DOOLEY RD. SUITE 200 ADDISON TX 75001 800-497-6059
Rapid Therapeutic Science Laboratories, Inc. (Filer) CIK: 0001575659 (see all company filings)

EIN.: 462111820 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55018 | Film No.: 221376806
SIC: 2834 Pharmaceutical Preparations